Loading

Annals of Clinical Cytology and Pathology

Toxocariasis in Brazilian Children: A Case-Control Study

Research Article | Open Access

  • 1. Department of Pediatrics, School of Medicine UFMG, Brazil
+ Show More - Show Less
Corresponding Authors
Elaine Carvalho, Department of Pediatrics, School of Medicine UFMG, Av.Prof.Alfredo Baleno 190, sala 267. Bairro Santo Efigenia. Belo Horizonte, Minas Gerais, Brazil, Tel: 55-31-9983-636-75
Abstract

Introduction: The identification of epidemiological, clinical, behavioral, and ultrasonographic and laboratory features could aid in the diagnosis of visceral larva migrans (VLM) in children and adolescents in Brazil.

Methods: A case-control study was conducted in ambulatory patients aged 6 months to 16 years cared for 4 years at a pediatric infectious diseases outpatient service in Belo Horizonte, Brazil. Patients with serum ELISA (enzyme-linked immunosorbent assay) anti-T. canis IgG antibody titers>1:640 were assigned to the case group, and the remaining subjects were assigned to the control group. The statistical significance of univariate associations between the outcome variable and exposure (i.e., epidemiological, clinical, behavioral, laboratory and ultrasonographic findings) was assessed using Pearson’s chi-square (χ2 ) test or Fisher’s exact test. Multiple logistic regression analyses were used to assess the independent effect of each variable on the odds of the serologic status.

Results: Thirty-seven cases and 31 controls were studied. In multiple analyses, residence in a rural area (OR = 4.23; 95% CI = 0.66-27.06), keeping a dog at home (OR = 9.71; 95% CI = 1.02-92.67), and total serum immunoglobulin E (IgE)>1,000 IU/ mL (OR = 2.05; 95% CI = 0.67-6.30) were the most important explanatory variables for VLM. Age, gender, hepatomegaly, splenomegaly, serum isohemagglutinins, total serum immunoglobulinG, immunoglobulin A (IgA) and immunoglobulinM, hypereosinophilia and abdominal ultrasonographic findings were not different in cases and controls.

Conclusions: Keeping dogs at home and residing in rural areas are important epidemiological risk factors for VLM. In the presence of one or more of these risk factors, patients should undergo anti-Toxocara ELISA. However; with larger sample studies should be performed.

Citation

de Almeida Carvalho EA, Rocha RL (2017) Toxocariasis in Brazilian Children: A Case-Control Study. Ann Clin Cytol Pathol 3(5): 1068.

INTRODUCTION

The term visceral larva migrans (VLM) was first proposed by Beaver et al. in 1952 to describe three cases of chronic extreme eosinophilia, hepatomegaly, pneumonitis, fever, cough and hyperglobulinemia in pediatric patients with second-stage larvae of a nematode parasite observed in granulomatous lesions from the liver1 .

Despite the high prevalence of toxocariasis in children from Brazil and abroad, there is still a paucity of epidemiological investigations on risk factors. Because the clinical suspicion of toxocariasis is sometimes challenging and delay in the diagnosis may be associated with serious complications in the eye, brain or liver, we conducted a case-control study to identify epidemiological, clinical, and ultrasonographic and laboratory features that could aid in the diagnosis of VLM in children and adolescents.

MATERIAL AND METHODS

Patients and setting

A case-control study was conducted using data collected from 68 ambulatory patients aged 6 months to 16 years cared for 4 years at the pediatric infectious diseases outpatient service of the Training and Reference Center for Infectious and Parasitic Diseases/,Belo Horizonte Health Secretary and affiliated with the Minas Gerais Federal University (UFMG),Brazil. All patients attending the outpatient service with absolute age-adjusted eosinophilia, impaired vision or liver abscess were eligible for the study. Excluded were patients diagnosed with cardiopathy, sickle cell anemia, leukemia, diabetes mellitus, HIV infection, chronic lung disease, primary or drug-induced immunosuppression, severe asthma or atopic dermatitis, and those who declined to give written informed consent.

Epidemiological, clinical and behavioral risk factors

The following epidemiological, clinical and behavioral data were gathered from clinical records using a standardized form: the location of residence (urban vs. rural); In addition, the following data regarding the last 3 months before diagnosis were gathered: keeping puppies (of up to 6 months-old) and dogs at home; history of use of anti-parasitic drugs by dogs at home; close contact with sand, sandboxes or soil; geophagy; onychophagy; and impaired vision (difficulty or blurred vision, or strabismus).

Laboratory data and abdominal ultrasonographic examination

Age-adjusted reference ranges for hemogram and serum Ig values were used. The parasitological stool examination was considered positive in the presence of protozoa and/ or helminthes. At abdominal ultrasonography, used to define hepatomegaly and splenomegaly. Intra-abdominal lymph node enlargement and/or hypoechoic liver nodules were also considered abnormal findings.

Serum anti-T.canis IgG antibody titers were determined using a commercially available enzyme-linked immunosorbent assay (ELISA), Ridascreen®Toxocara IgG (Darmstadt, Germany), which detects antibodies against T. canis excretory-secretory larval antigens. Patients with titers >1:640 were allocated to the case group (37) and patients with titers ≤ 1:640 were allocated to the control group (31).

Data analysis

The values of the continuous variables were grouped into clinically relevant categories for statistical analysis, according to normal range values. The statistical significance of univariate associations between the outcome variable and exposure variables was assessed using Pearson’s chi-square (χ2 ) test or Fisher’s exact test, as appropriate. Statistical significance of univariate comparisons was set at p<0.05 (two-tailed). For statistically significant variables, odds ratios (OR) and 95% confidence intervals (CI) were computed as measures of effect size.Multiple logistic regression analyses were used to assess the independent effect of each variable on the odds of the serologic status.

RESULTS

Sixty-eight patients were recruited aged from 10 months to 14.6 years (mean 6.7 years, median 6.6 years). Most children (66.2%) were between 10 months and 7 years-old. Males were predominant in both the cases (56.8%) and controls (67.7%) (Table 1).

A history of other parasitosis was similar among the cases and controls. Most children had contact with sand, sandboxes or soil, and 97.2% kept a dog at home. Approximately two-thirds of families of cases and controls earned ≤ 1 official minimum wage per month.

As for signs, symptoms and behaviors reported by patients, parents or caregivers, fever was infrequently recorded among the cases and controls. Onychophagy and geophagyprevailed among the cases (Table 2).

At physical examination, the prevalences of clinical hepatomegaly and splenomegaly among the cases were similar. At fundoscopy, 5.9% of the cases were diagnosed with retinitis (Table 3).

Abdominal ultrasonographic findings were found in 11 cases (29.7%) and liver abscess was found in 2 cases (Table 4).

Blood leukocyte counts (median value 9,275/mm3 and maximum value 73,000/mm3 ) and median blood eosinophil counts for all patients (1,396/mm3 ) were not significantly different between the cases and controls. Median and maximum serum IgE levels for the case-patients were 791 IU/mL and 2,500 IU/mL, respectively. High levels of IgE were present in 97.2% of the cases, with IgE levels >1,000 IU/mL present in 50% of the cases. High levels of serum IgG, IgA and IgM were observed in 41.7%, 10.8% and 16.2% of the cases, respectively. Parasitological stool examination was positive for Schistosoma mansoni (3), Strongyloidesstercolaris (2) and Ascarislumbricoides (2) (Table 4).

Following the procedures described in the Data Analysis, candidate variables for the multivariate model were location of residence, number of children in the household, keeping a dog at home, geophagy, and total serum IgE > 1,000 IU/mL. Table 6 reports the final logistic regression model for VLM, showing that residence in a rural area, keeping a dog at home, and total serum IgE>1,000 IU/mL remained as the most important explanatory variables for VLM. In the presence of all 3 factors, a serum ELISA anti-T.canis IgG titer>1:640 would be expected in 89.4% of pediatric patients. For children who reside in rural areas and who either keep dogs at home or have a total serum IgE>1,000 IU/mL, the expected prevalence would be 80.4% and 66.6%, respectively (Table 5)

Table 1: Univariate associations between case-control status and epidemiological and socio-demographic exposure variables.

  Controls Cases Total   OR (95% CI)
Variable N % N % N % p-value
Gender             0.454 0.63
Female 10 32.3 16 43.2 26 38.2   (0.20-1.89)
Male 21 67.7 21 56.8 42 61.8    
Total 31 100 37 100 68 100    
Age             0.330 0.58
≤ 5 years 11 35.5 18 48.6 29 42.6   (0.19-1.72)
≥ 6 years 20 64.5 19 51.4 39 57.4    
Total .1 100 37 100 68 100    
Keeping dog at home             0.009 12.73
(1.48-108.8)
No 8 26.7 1 2.8 9 13.6  
Yes 22 73.3 35 97.2 57 86.4  
Total 30 100 36 100 66 100  
Keeping puppy at home             0.268 2.54
No 5 19.2 3 8.6 8 13.1   (0.46-15.32)
Yes 21 80.8 32 91.4 53 86.9    
Total 26 100 35 100 61 100    
History of use of antiparasitic drugs by dog at home           0.746 1.38
No 18 81.8 26 76.5 44 78.6   (0.31-6.54)
Yes 4 18.2 8 23.5 12 21.4    
Total 22 100 34 100 56 100    
Close contact with sand, sandboxes or soil           0.655 1.83
No 3 10 2 5.7 5 7.7   (0.22-17.16)
Yes 27 90 33 94.3 60 92.3    
Total 30 100 35 100 65 100    
Location of residence             0.166 0.26
(0.03-1.51)
Rural 2 6.7 8 21.6 10 14.9  
Urban 28 93.3 29 78.4 57 85.1  
Total 30 100 37 100 67 100    

Table 2: Univariate associations between case-control status and signs, symptoms and behaviors reported by patients, parents or caregivers.

  Controls Cases Total   OR (95% CI)
Variable N % N % N % p-value
Onychophagy             0.332 1.68
No 18 60 17 47.2 35 53   (0.56-5.04)
Yes 12 40 19 52.8 31 47    
Total 30 100 36 100 66 100    
Geophagy             0.105 2.70
No 25 83.3 24 64.9 49 73.1   (0.74-10.38)
Yes 2 16.7 13 35.1 18 26.9    
Total 30 100 37 100 67 100    
Impaired vision             1.000  
No 29 100 36 97.3 65 98.5   -
Yes - - 1 2.7 1 1.5    
Total 29 100 37 100 66 100    

Table 3: Univariate associations between case-control status and findings at physical examination.

  Controls Cases Total   OR (95% CI)
Variable N % N % N % p-value
Splenomegaly             0.588 0.40
No 29 93.5 36 97.3 65 95.6   (0.01-0.12)
Yes 2 6.5 1 2.7 3 4.4    
Total 31 100 37 100 68 100    
Hepatomegaly             0.525 1.49
No 27 87.1 29 78.4 56 82.4   (0.48-4.69)
Yes 4 12.9 8 21.6 12 17.6    
Total 31 100 37 100 68 100    
Peripherallymphadenomegaly                
No 28 90.3 30 81.1 58 85.3 0.326 2.18
Yes 3 9.7 7 18.9 10 14.7   (0.44-11.94)
Total 31 100 37 100 68 100    
Fundoscopy             0.495 -
Normal 29 100 32 94.1 61 96.8    
Abnormal - - 2 5.9 2 3.2    
Total 29 100 34 100 63 100    

Table 4: Univariate associations between case-control status and laboratory and findings from abdominal ultrasonography results.

  Controls Cases Total   OR (95% CI)
Variable N % N % N % p-value
Blood leukocytes count             0.549 0.66
Normal 24 77.4 31 83.8 55 80.9   (0.17-2.59)
Abnormal 7 22.6 6 16.2 13 19.1    
Total 31 100 37 100 68 100    
Blood eosinophil count (age-adjusted)           0.494 1.98
Normal 6 19.4 4 10.8 10 14.7   (0.43-9.55)
Abnormal 25 80.6 33 89.2 58 85.3    
Total 31 100 37 100 68 100    
Blood eosinophil count >1,000/mm3           1.000 0.57
Normal 10 32.3 12 32.4 22 32.4   (0.20-1.62)
Abnormal 21 67.7 25 67.6 46 67.6    
Total 31 100 37 100 68 100    
Total serum IgE             0.582 2.59
Normal 2 6.9 1 2.8 3 4.6   (0.17-76.54)
Abnormal 27 93.1 35 97.2 62 95.4    
Total 29 100 36 100 65 100    
Total serumIgE > 1,000 IU/mL             0.138 2.22
(0.80- 6.18)
No 20 69 18 50 38 58.5  
Yes 9 31 18 50 27 41.5  
Total 29 100 36 100 65 100    
Total serumIgG             0.301 0.63
Normal 21 72.4 21 58.3 42 64.6   (0.15-2.61)
Abnormal 8 27.6 15 41.7 23 35.4    
Total 29 100 36 100 65 100    
Total serumIgA             0.688 1.64
Normal 27 93.1 33 89.2 60 90.9   (0.23-14.08)
Abnormal 2 6.9 4 10.8 6 9.1    
Total 29 100 37 100 66 100    
Total serumIgM             0.289 2.61
Normal 27 93.1 31 83.8 58 87.9   (0.42-20.59)
Abnormal 2 6.9 6 16.2 8 12.1    
Total 29 100 37 100 66 100    
Parasitological stool examination           0.177 0.451
Negative 18 62.1 29 78.4 47 71.2   (0.13-1.51)
Positive 11 37.9 8 21.6 19 28.8    
Total 29 100 37 100 66 100    
Hepatomegaly             1.000 0.79
No 19 95 24 96 43 95.6   (0.02-31.14)
Yes 1 5 1 4 2 4.4    
Total 20 100 25 100 45 100    
Liver abscess             0.496 -
No 31 100 35 94.6 66 97.1    
Yes - - 2 5.4 2 2.9    
Total 31 100 37 100 68 100    
Liver hypoechoic nodules and/or periportal lymphadenomegaly           0.405 1.76
No 25 80.6 26 70.3 51 75   (0.50-6.40)
Yes 6 9.4 11 29.7 17 25    
Total 31 100 37 100 68 100    

 

DISCUSSION

The development of currently available immunodiagnostic tests that can accurately diagnose VLM is the last step in a series of developments in VLM that began several decades ago with the first reports linking T. canis infection to systemic disease in human hosts.

For symptomatic children, keeping a dog at home was associated with almost 10-fold higher odds of having a serum ELISA anti-T. canis IgG titer>1:640 compared to children that did not own dogs. Other variables, such as the number of children in the household, geophagy, living in a rural area and a serum IgE>1,000 IU/mL, were also candidate variables for the multivariate model. In the final model, however, residence in a rural area, keeping a dog at home, and total serum IgE>1,000 IU/ mL remained as the most important explanatory variables for VLM [1]. In the presence of all 3 factors, a serum ELISA anti-T. canis IgG titer>1:640 would be expected in 89.4% of pediatric patients.

In line with previous case-control studies [2-8], age was not associated with VLM prevalence in our sample. As previously reported in other parts of Brazil [4,9,10], VLM was more frequently observed in children older than 5. Conversely, in industrialized countries, VLM is more prevalent among children younger than 7 [11].

More case-patients in our study were males, with a male-to-female ratio of 1.3:1. Similar results were reported by several authors [12], with male-to-female ratios ranging between 1.5:1 and 2.3:1 [5,13]. However, in accordance with most published studies [2,4,6,7,9,14-17], being of male gender did not pose a statistically significant higher risk of VLM to patients. The higher prevalence of toxocariasis in male patients could be explained partially by the tendency of boys to be less stringent than girls about personal hygiene, making them more prone to infections. Impaired vision and pathologic fundoscopic findings were not more frequent among VLM patients, but the prevalence of ocular larva migrants [18,19], and age of presentation were comparable to previous reports.

Adults and children residing in rural areas are at increased risk of acquiring toxocariasis [6,8]. We estimated that patients residing in rural areas had approximately 4-fold higher odds for VLM than patients residing in urban areas.

As confirmed by our study and previous investigations [6- 8,15,17], children owning a pet dog are at higher risk of acquiring toxocariasis. Although other authors reported an association between owning puppies younger than 3 months old and serum anti-T.canis ELISA positivity [14,15], our study did not confirm any significant association between VLM and owning puppies younger than 6 months old or previous use of anti-parasitic drugs by dogs at home.

Close contact with soil, sand or sandboxes has long been implicated as a risk factor for toxocariasis [14] but was not associated with increased risk in our study or in a previous report [8]. The behavioral disorder of eating earthy substances, such as soil, clay, chalk or mud, which is frequent among children between 18 months and 3 years old, increases the likelihood of eating T. canis ova and has been found to be a risk factor for toxocariasis in some studies [2,11]. However, we and others [14,17,20]failed to demonstrate such an association. Additionally, studies investigating the association between onicophagy and toxocariasis have shown conflicting results [4,14]. Onicophagy, common among school-age children, is sometimes considered a correlate of geophagy, more common in infants and preschoolers.

Leukocytosis and eosinophilia were not more frequent among the cases than the controls. Among the cases, the highest blood leukocyte count was 73,000/mm3 , and 48.4% had blood eosinophil counts ranging from 1,001 to 2,000/mm3 . The association between eosinophilia and serum anti-Toxocara positivity has also been highly inconsistent in the literature [6,8]. Other studies using different cut-off points for eosinophilia also found significant relationships between anti-T. canis serology and blood eosinophil counts higher than 400/mm [3,14], 1,000/ mm [3,19], 2,000/mm [3,20] and 3,000/mm [3,9]. In our study, instead of using a single cut-off point for eosinophilia, we used age-adjusted reference values but did not observe higher eosinophil counts in the cases than in the controls. We hypothesize that eosinophilia may have been the manifestation of underlying diseases such as asthma, atopic dermatitis or exposure to other parasitosis with a life cycle involving the lungs.

The hyperimmunoglobulinemia E is a common finding in both adults [6] and children [14] with toxocariasis. We retained serum IgE> 1,000 IU/mL in the final logistic regression model because, although not statistically significant, it was associated with a 2-fold increase in the odds of VLM in our sample. The IgA, IgG and IgM titers were not predictive of VLM in our study and in other studies [14]. Because IgG intervenes in the humoral response to T. canis infection, we cannot rule out a lack of statistical power to detect a significant antibody rise.

The splenomegaly [14] and the hepatomegaly are not common features of VLM, although some authors reported liver enlargement in patients with toxocariasis [14]. Using routine ultrasound scanning, we were able to detect several pathologic findings in both the cases and controls. Among the case-patients, 2 had liver abscesses and 17 had hypoechoic liver nodules, with 45.5% of the latter also diagnosed with hepatomegaly. Among the controls, 6 had periportallymphadenomegaly. No ultrasonographic finding was statistically more frequent in the cases than in the controls, but the small sample size of our study and the rare event nature of these ultrasonographic findings preclude any firm conclusions. The possibility also exists that some controls may arguably be past toxocariasis patients with liver and/or abdominal lesions in a regression phase, attenuating the differences between the cases and controls toward the null.

The definite diagnosis of toxocariasis needs the demonstration of the pathogen by biopsy. However, because this is an invasive procedure, serodiagnosis using anti-Toxocara ELISA is acceptable. In children, serum anti-Toxocara antibodies remain detectable at high titers for at least 2 to 4 years [21]. In summary, this report demonstrates that keeping dogs at home and residing in rural areas are important epidemiological risk factors for VLM. In the presence of 1 or more of these risk factors, patients should undergo anti-Toxocara ELISA serology. Further work is needed to define serologic markers of disease severity.

Table 5: Final logistic regression model for visceral larva migrans.

Variable β S.E. OR 95% CI p-value
Location of residence (reference: urban)        
Rural 1.442 0.947 4.23 0.66-27.06 0.128
Keeping dog at home (reference: no)        
Yes 2.273 1.151 9.71 1.02-92.67 0.048
Total serum IgE (reference: ≤ 1,000 IU/mL)        
>1,000 IU/mL 0.718 0.573 2.05 0.67-6.30 0.210
Intercept -2.302 1.151 - - 0.045
β: regression coefficient; S.E.: Standard Error; OR: Odds Ratio; CI: Confidence Interval; IU: International Units Hosmer-Lemeshow goodness-of-fit test, p = 0.878

 

REFERENCES

1. Beaver PC, Snyder CH, Carrera GM, Dent JH, Lafferty JW. Chronic eosinophilia due to visceral larva migrans; report of three cases. Pediatrics. 1952; 9: 7-19.

2. Ajayi OO, Duhlinska DD, Agwale SM, Njoku M. Frequency of human toxocariasis in Jos, Plateau State, Nigeria. Mem Inst Oswaldo Cruz. 2000; 95: 147-149.

3. Kanafani ZA, Skoury A, Araj GF, El-Khoury M, Sawaya RA, Atweh SF, et al. Seroprevalence of toxocariasis in Lebanon: a pilot study. Parasitology. 2006; 132: 635-639.

4. Alderete JM, Jacob CM, Pastorino AC, Elefant GR, Castro AP, Fomin AB, et al. Prevalence of Toxocara infection in schoolchildren from the Butantã region, São Paulo, Brazil. Mem Inst Oswaldo Cruz. 2003; 98: 593-597.

5. Altcheh J, Nallar M, Conca M, Biancardi M, Freilij H. [Toxocariasis: clinical and laboratory features in 54 patients]. An Pediatr (Barc). 2003; 58: 425-431.

6. Gonzalez-Quintela A, Gude F, Campos J, Garea MT, Romero PA, Rey J, et al. Toxocara infection seroprevalence and its realtionship with atopic features in a general adult population. Int Arch Allergy Immunol. 2006; 139: 317-324.

7. Fan CK, Liao CW, Kao TC, Li MH, Du WY, Su KE. Sero-epidemiology of Toxocara canis infection among aboriginal schoolchildren in the mountainous areas of north-eastern Taiwan. Ann Trop Med Parasitol. 2005; 99: 593-600.

8. Anaruma Filho F, Chieffi PP, Correa CR, Camargo ED, Silveira EP, Aranha JJ, et al. Human toxocariasis: a seroepidemiological survey in the municipality of Campinas (SP), Brazil. Rev Inst Med Trop Sao Paulo. 2002; 44: 303-307.

9. Aguiar-Santos AM, Andrade LD, Medeiros Z, Chieffi PP, Lescano SZ, Perez EP. Human toxocariasis: frequency of anti-Toxocara antiobodies in children and adolescents from na outpatient clinic for lymphatic filariasis in Recife, northeast Brazil. Rev Inst Med Trop S Paulo. 2004; 46: 81-85.

10. Muradian V, Gennari SM, GlickmanLT, Pinheiro SR. Epidemiological aspects of Visceral Larva Migrans in children living at São Remo Community, São Paulo (SP), Brazil. Vet Parasitol. 2005; 134: 93-97.

11. Mok CH. Visceral larva migrans. A discussion based on review of the literature. Clin Pediatr (Phila). 1968; 7: 565-573.

12. Kanafani ZA, Skoury A, Araj GF, El-Khoury M, Sawaya RA, Atweh SF, et al. Seroprevalence of toxocariasis in Lebanon: a pilot study. Parasitology. 2006; 132: 635-639.

13. Sabrosa NA, de Souza EC. Nematode infections of the eye: toxocariasis and diffuse unilateral subacute neuroretinitis. Curr Opin Ophthalmol. 2001; 12: 450-454.

14. Figueiredo SD, Taddei JA, Menezes JJ, Novo NF, Silva EO, Cristóvão HL, et al. [Clinical-epidemiological study of toxocariasis in a pediatric population]. J Pediatr (Rio J). 2005; 81: 126-132.

15. Iddawela DR, Kumarasiri PV, de Wijesundera MS. A seroepidemiological study of toxocariasis and risk factors for infection in children in Sri Lanka. Southeast Asian J Trop Med Public Health. 2003; 34: 7-15.

16. Campos Júnior D, Elefant GR, de Melo e Silva EO, Gandolfi L, Jacob CM, Tofeti A, et al. [Frequency of seropositivity to Toxocara canis in children of different socioeconomic strata]. Rev Soc Bras Med Trop. 2003; 36: 509-513.

17. Coelho LM, Silva MV, Dini CY, Giacon Neto AA, Novo NF, Silveira EP. Human toxocariasis: a seroepidemiological survey in schoolchildren of Sorocaba, Brazil. Mem Inst Oswaldo Cruz. 2004; 99: 553-557.

18. Good B, Holland CV, Taylor MR, Larragy J, Moriarty P, O’Regan M. Ocular toxocariasis in schoolchildren. Clin Infect Dis. 2004; 39: 173- 178.

19. Altcheh J, Nallar M, Conca M, Biancardi M, Freilij H. [Toxocariasis: clinical and laboratory features in 54 patients]. An Pediatr (Barc). 2003; 58: 425-431.

20. Lopez Mde L, Martin G, Chamorro Mdel C, Mario Alonso J. [Toxocariasis in children from a subtropical region]. Medicina (B Aires). 2005; 65: 226-230.

21. Cypess RH, Karol MH, Zidian JL, Glickman LT, Gitlin D. Larva-specific antibodies in patients with visceral larva migrans. J Infect Dis. 1977; 135: 633-640.

Received : 27 May 2017
Accepted : 28 Jun 2017
Published : 30 Jun 2017
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X